Han Schmidly
Internal Medicine · Dallas, TXNPI 1770593436
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $296,577 of the $464,809 with a category attached, or 63.8%. Organogenesis Inc. accounts for 99.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $94,825 and has fallen 68.7% since, to $29,657 in 2025. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,135 payments — averaging $409.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$463K
- Smith+Nephew$1K
- AbbVie$256
- Biotissue Holdings Inc.$124
- Solventum Corporation$115
- KCI USA, Inc.$107
- plus $232 from 7 others
What the payments were for
- Consulting fees$78,38217%
- Speaking & faculty fees$296,57764%
- Travel & lodging$79,87017%
- Food & beverage$9,9792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 1,024 | $462,673 |
| Smith+Nephew | 76 | $1,301 |
| AbbVie(2 entities) | 12 | $256 |
| Biotissue Holdings Inc. | 2 | $124 |
| Solventum Corporation | 5 | $115 |
| KCI USA, Inc. | 4 | $107 |
| Convatec Inc. | 3 | $67 |
| Integra Lifesciences Corporation | 3 | $63 |
| Osiris Therapeutics Inc. | 2 | $34 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Bsn Medical Inc | 1 | $18 |
| Pylant Medical | 1 | $18 |
| Misonix Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$196,242
- Apligraf$116,480
- Puraply Antimicrobial$92,400
- Dermagraft$91,051
- Puraply/Affinity/NuTech$91,051
- Affinity$48,800
- PURAPLY WOUND MATRIX$39,628
- NOVACHOR$34,199
- NuShield$25,428
- GRAFIX PL$143
- Allevyn Life$143
- Santyl$143
- Stravix$111
- Grafix$111
- GrafixPL$111
- NEOX$101
- CLARIX$101
How this compares
$464,809 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 29 | $471 |
| Clindamycin Hcl | 21 | $368 |
| Ciprofloxacin Hcl | 17 | $199 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $123 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Dallas
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Athica VatanapradithDallas$164K
- Nicholaos BellosDallas$113K
- Steven HeldDallas$65K
- Amit VermaDallas$53K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Mohammed Al-NajjarEl Paso$586K
- Hussein TawbiHouston$365K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.